ERBB2 and gastric cancer: Receptor mediated targeting of gastric cancer (GC) cells was accomplished by overexpressing HER2, using precision engineering of nanoparticles of biodegradable copolymers to quantitatively control AMO-21 delivery (Figure 1A).